Anson Funds Management’s Merck MRK Stock Holding History

Anson Funds Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$1.99M	–	159
2024 Q4	$1.99M	Hold	20,000	–	–	0.2%	73
2024 Q3	$2.27M	Buy	+20,000	New	+$2.38M	0.23%	74
2024 Q1	–	Sell	-15,000	Closed	-$1.64M	–	189
2023 Q4	$1.64M	Buy	+15,000	New	+$1.56M	0.2%	75
2021 Q1	–	Sell	-15,720	Closed	-$1.23M	–	281
2020 Q4	$1.23M	Hold	15,720	–	–	0.25%	95
2020 Q3	$1.24M	Buy	+15,720	New	+$1.23M	0.67%	42

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Anson Funds Management's MRK Position: Q1 2025 in Review

Anson Funds Management sold out of Merck (MRK) in Q1 2025, closing a stake of 20,000 shares — an estimated $1.99M sold.

Anson Funds Management first reported a position in MRK in Q3 2020 and held it in 5 quarters. The position peaked at $2.27M in Q3 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Anson Funds Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Anson Funds Management sold 20,000 Merck shares in Q1 2025, an estimated $1.99M.
Anson Funds Management first reported a position in Merck in Q3 2020 and held it in 5 quarters.
Anson Funds Management's Merck position peaked at $2.27M in Q3 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Anson Funds Management's 13F filing for Q1 2025, filed 14 May 2025.